News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DNAPrint Pharmaceuticals Announces Discovery Of Genetic Marker For Statin-Induced Myalgia



12/19/2006 10:40:51 AM

SARASOTA, FL -- (MARKET WIRE) -- December 19, 2006 -- DNAPrint Genomics, Inc. (OTCBB: DNAG), today announced that the Company's research staff has discovered a genetic marker for statin-induced myalgia (chronic muscle pain), that a patent has been filed to protect the discovery and that the research on which the discovery is based will be published in an upcoming issue of The Journal of Pharmacogenetics and Genomics (JPG).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES